CDNA vs ADPT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

CDNA

34.0
AI Score
VS
ADPT Wins

ADPT

41.7
AI Score

Investment Advisor Scores

CDNA

34score
Recommendation
SELL

ADPT

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CDNA ADPT Winner
Revenue 249.65M 142.43M CDNA
Net Income 113.44M -59.82M CDNA
Net Margin 45.4% -42.0% CDNA
Operating Income 114.42M -34.98M CDNA
ROE 26.7% -41.9% CDNA
ROA 21.3% -9.3% CDNA
Total Assets 532.99M 640.68M ADPT
Cash 373.64M 169.87M CDNA
Current Ratio 4.58 4.79 ADPT
Free Cash Flow 29.26M -17.92M CDNA

Relative Price Performance (Last 90 Days)

CDNA 1M: +29.2% · 3M: +125.4% ADPT 1M: +16.5% · 3M: +87.4%

Current Technical Phase

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (34.1% over 20 days), RSI 72

RSI (14): 71.8 · Price: $48.61

ADPT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (20.8% over 20 days), RSI 65

RSI (14): 65.5 · Price: $25.99

Fundamentals Snapshot

Metric CDNA ADPT
Market Cap
Forward P/E 35.9 -140.7
Trailing P/E 22.4
Revenue (TTM)
Revenue Growth 0.5% 0.2%
Gross Margin 0.7% 0.5%
Operating Margin 0.0% -0.2%
EPS 2.10 -0.40
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ADPT is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.